BiotechTube
Home/Qlaris Bio/Kevin Bitter
KB

Kevin Bitter

Senior Vice President, Strategy and Corporate Development

Qlaris Bio

Therapeutic Areas

OphthalmologyGlaucoma

Qlaris Bio Pipeline

DrugIndicationPhase
QLS-111Primary Open-Angle Glaucoma, Ocular HypertensionPhase 1

Leadership Team at Qlaris Bio

FG
Fred Guerard, Pharm.D.
President and Chief Executive Officer
BW
Barbara Wirostko, MD, FARVO
Chief Medical Officer and Co-founder
MF
Michael Fautsch, PhD
Chair, Scientific Advisory Board
View full Qlaris Bio profile